The production of synthetic MHC-peptide tetramers has revolutionized cellul
ar immunology by revealing enormous CD8(+) T cell expansions specific for p
eptides from various pathogens. A feature of these reagents, essential for
their staining function, is that they bind T tells with relatively high avi
dity. This could, theoretically, promote cross-reactivity with irrelevant T
cells leading to overestimates of epitope-specific T cell numbers. Therefo
re, we have investigated the fine specificity of CTL staining with these re
agents for comparison with functional data. Using a panel of CTL clones wit
h distinct fine specificity patterns for analogs of an HLA-B8-binding EBV e
pitope, together with B8 tetramers incorporating these peptides, we show a
very good correlation between tetramer staining and peptide activity in cyt
otoxicity assays. Significant staining only occurred with tetramers that in
corporate strong stimulatory agonist peptides and not weak agonists that ar
e unlikely to induce full T cell activation at physiological levels of pres
entation. In almost every case where a peptide analog had >10-fold less act
ivity than the optimal EBV peptide in cytotoxicity assays, the correspondin
g tetramer stained with >10-fold less intensity than the EBV epitope tetram
er, Furthermore, by examining an EBV-specific clonotypic T cell expansion i
n EBV-exposed individuals, we show similar fine specificity in tetramer sta
ining of fresh peripheral T cells. Collectively, our data demonstrate the e
xquisite specificity of class I MHC-peptide tetramers, underlining their ac
curacy in quantifying only those T cells capable of recognizing the low lev
els of cell surface peptide presented after endogenous Ag processing.